Skip to main content
OpenTrials
Completed

NCT Number: NCT02670902

Intervention for Persons Leaving Residential Substance Abuse Treatment

This research uses a multi-phase approach to adapt and implement an established intervention, Critical Time Intervention, for a new population and setting among individuals with substance use who are at risk of relapse following residential substance abuse treatment. The goals of the study are to: (PHASE 1) identify challenges and strategies of community reentry among individuals in residential substance abuse treatment and their providers and social support networks (e.g., family, friends, community members); (PHASE 2) adapt CTI for individuals in residential substance abuse treatment to prepare them for discharge and transition back into the community; and (PHASE 3) conduct a pilot study to examine the feasibility, acceptability, and preliminary outcomes of the adapted CTI compared to enhanced usual discharge planning services.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

New York University

New York, 10003, United States

About this study

This randomized pilot study will examine the feasibility, acceptability, and preliminary outcomes of the adapted CTI compared to enhanced usual discharge planning services. More specifically, 60 participants will be randomized to either CTI (n=30) or enhanced usual discharge planning services (n=30) at the time of discharge. Participants will complete a baseline interview (prior to randomization) and 3-, 6-, 9- and 12-month follow-up assessments post-discharge.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Eligible participants will be enrolled in residential substance abuse treatment and who are at least 18 years of age, speak English, and expect to be discharged within 3 months.

Exclusion criteria

  • Individuals that do not meet the aforementioned inclusion criteria will be excluded from the study.More specifically, the following categories will be excluded:
  • Anyone under the age of 18
  • Non-English speaking individuals due to limited resources
  • Individuals who are considered vulnerable/protected populations, including children, pregnant women, and prisoners.
  • Individuals judged by clinical treatment staff to be in immediate crisis, i.e., suicide watch or inadequate decisional capacity to participate in the study.

Treatment and study plan

Critical Time Intervention-Residential (CTI-R)

Behavioral

CTI-R is a 9-month, time-limited intervention that aims to produce an enduring impact by effectively linking individuals to both professional services (substance abuse and health and mental health providers) and social supports (e.g., family and friends) and by providing emotional and practical support. Participants in the CTI-R condition will also receive usual discharge services from the residential substance abuse treatment program.

Enhanced Usual Discharge Services-Residential

Behavioral

The enhanced usual discharge condition encompasses the regular discharge services offered at the residential treatment program plus enhanced transition services.

Primary outcomes

  1. Enrollment

    Time frame: Baseline

    Proportion of participants enrolled in the study as measured by the research records

  2. Change in retention

    Time frame: 3, 6, 9, and 12 months

    Proportion of participants completed the study as measured by the research records

  3. Short-term Relapse

    Time frame: 3 months

    Proportion of participants who relapsed (i.e., substance use) as measured by Addiction Severity Index

  4. Use of aftercare services

    Time frame: 3 months

    Proportion of participants who were linked to aftercare services (i.e. substance use treatment) at the time of discharge as measured by the Treatment Service Review (TSR)

  5. Housing

    Time frame: 3 months

    Proportion of participants housed at the time of discharge

Secondary outcomes

  1. Short-term Social Support

    Time frame: 3 months

    Level of social support as measured by the 8-item modified Medical Outcomes Study Social Support Survey

  2. Short-term Self-Efficacy

    Time frame: 3 months

    Level of self-efficacy as measured by "I feel like I'm in control of my alcohol or drug use."

  3. Short-term Mental Health

    Time frame: 3 months

    Level of mental health severity as measured by the Brief Symptom Inventory

  4. Change in Relapse

    Time frame: 3, 6, and 9 months

    Proportion of participants who relapsed (i.e., substance use) as measured by Addiction Severity Index

  5. Long-term Relapse

    Time frame: 12 months

    Proportion of participants who relapsed (i.e., substance use) as measured by Addiction Severity Index

  6. Change in Social Support

    Time frame: 3, 6, and 9 months

    Level of social support as measured by the 8-item modified Medical Outcomes Study Social Support Survey

  7. Long-term Social Support

    Time frame: 12 months

    Level of social support as measured by the 8-item modified Medical Outcomes Study Social Support Survey

  8. Change in Self-Efficacy

    Time frame: 3, 6, and 9 months

    Level of self-efficacy as measured by "I feel like I'm in control of my alcohol or drug use."

  9. Long-term Self-Efficacy

    Time frame: 12 months

    Level of self-efficacy as measured by "I feel like I'm in control of my alcohol or drug use."

  10. Change in Mental Health

    Time frame: 3, 6, and 9 months

    Level of mental health severity as measured by the Brief Symptom Inventory

  11. Long-term Mental Health

    Time frame: 12 months

    Level of mental health severity as measured by the Brief Symptom Inventory

Sponsors and collaborators

Lead sponsor

New York University

Other

Registry information

Official study title

Intervention for Persons With Co-Occurring Disorders Leaving Residential Tx

Important dates

Study start
2017
Primary completion
2020
Study completion
2020
First posted
Feb 2, 2016
Registry last updated
Nov 1, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.